Thieroff-Ekerdt; Ruth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thieroff-Ekerdt; Ruth.The latest application filed is for "glycan preparations and methods of use for hyperammonemia".

Company Profile

1.13.10

Thieroff-Ekerdt; Ruth - Lexington MA
THIEROFF-EKERDT; Ruth - Concord MA
THIEROFF-EKERDT; Ruth - Mendham NJ
Thieroff-Ekerdt; Ruth - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glycan Preparations And Methods Of Use For Hyperammonemia App 20220233577 - Gibson; Molly Krisann ; et al.	2022-07-28
Short-acting Selective Glucocorticoid Receptor Modulators App 20220072009 - THIEROFF-EKERDT; Ruth	2022-03-10
Digestive Enzyme Composition Suitable For Enteral Administration App 20210283229 - EREN; Devrim ; et al.	2021-09-16
Digestive enzyme composition suitable for enteral administration Grant 10,993,996 - Eren , et al. May 4, 2	2021-05-04
Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency App 20160051472 - Perrett; Stephen ; et al.	2016-02-25
Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency App 20140287035 - Perrett; Stephen ; et al.	2014-09-25
Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency Grant 8,784,884 - Perrett , et al. July 22, 2	2014-07-22
Pancreatic Enzyme Compositions and Methods for Treating Pancreatitis and Pancreatic Insufficiency App 20110064799 - Perrett; Stephen ; et al.	2011-03-17
Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions App 20110003005 - Venkatesh; Gopi ; et al.	2011-01-06
Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Grant 7,211,680 - Steinmeyer , et al. May 1, 2	2007-05-01
New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments App 20050080058 - Steinmeyer, Andreas ; et al.	2005-04-14
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Grant 6,642,218 - Steinmeyer , et al. November 4, 2	2003-11-04
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents Grant 6,613,920 - Steinmeyer , et al. September 2, 2	2003-09-02
Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Grant 6,600,058 - Steinmeyer , et al. July 29, 2	2003-07-29
New Vitamin D Derivatives With Carbo-or Heterocyclic Substituents At C-25, A Process For Their Production, Intermediate Products And Their Use For Producing Medicaments App 20020049344 - STEINMEYER, ANDREAS ; et al.	2002-04-25
Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof Grant 5,700,791 - Steinmeyer , et al. December 23, 1	1997-12-23
24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom Grant 5,665,716 - Kirsch , et al. September 9, 1	1997-09-09
20-position modified pharmaceutically active vitamin D series compounds Grant 5,585,368 - Steinmeyer , et al. * December 17, 1	1996-12-17
Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents Grant 5,532,228 - Neef , et al. July 2, 1	1996-07-02
20-methyl-substituted vitamin D derivatives Grant 5,446,035 - Neef , et al. August 29, 1	1995-08-29
23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents Grant 5,411,949 - Neef , et al. May 2, 1	1995-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.